AIDOT
Songpadong
About AIDOT
AIDot developed Cerviray A.I., an artificial intelligence-based diagnostic solution that combines traditional cervical enlargement photography and artificial intelligence to make cervical cancer screening faster and more accurate -- in fact, we’ve achieved 90% accuracy in a certified test report in 2019. This is in contrast to the 50% false-negative rate common for cervical cancer tests. AIDOT's solution is handheld and uses a mobile phone or tablet. It enables any relevant healthcare professional to detect cervical dysplasia and cancer with just one click and around ten seconds of AI analysis, compared to around one week for traditional tests.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2021)
- Website: aidot.ai
- Phone: 82-10-2500-2369
Industries & Categories
Artificial Intelligence (AI), Machine Learning, Medical, Software
Social Profiles
Canonical: https://fsome.com/organization/aidot-11788 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.